Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?
作者： Jordi Remon , Julie Gorham , Benjamin Besse , Jean-Paul Sculier
DOI: 10.1183/13993003.01482-2015
关键词:
摘要: cfDNA concentration might be a prognostic factor in NSCLC and could tool for detecting molecular alterations http://ow.ly/TF8TC
core.ac.uk
ulb.ac.be
sci-hub.se 参考文章(29)
Sávia R.C. Normando, Felipe M. Cruz, Auro del Giglio, Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer. Anti-Cancer Drugs. ,vol. 26, pp. 995- 1003 ,(2015) , 10.1097/CAD.0000000000000268
Glenn Francis, Sandra Stein, Circulating Cell-Free Tumour DNA in the Management of Cancer International Journal of Molecular Sciences. ,vol. 16, pp. 14122- 14142 ,(2015) , 10.3390/IJMS160614122
Jean-Yves Douillard, Gyula Ostoros, Manuel Cobo, Tudor Ciuleanu, Rebecca Cole, Gael McWalter, Jill Walker, Simon Dearden, Alan Webster, Tsveta Milenkova, Rose McCormack, Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status Journal of Thoracic Oncology. ,vol. 9, pp. 1345- 1353 ,(2014) , 10.1097/JTO.0000000000000263
Jie Luo, Li Shen, Di Zheng, Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis Scientific Reports. ,vol. 4, pp. 6269- 6269 ,(2015) , 10.1038/SREP06269
Ioannis Gioulbasanis, Athanasios Pallis, Panagiotis J. Vlachostergios, Alexandros Xyrafas, Zoe Giannousi, Isidora-Eleni Perdikouri, Michalitsa Makridou, Dionysia Kakalou, Vassilios Georgoulias, The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer. Lung Cancer. ,vol. 77, pp. 383- 388 ,(2012) , 10.1016/J.LUNGCAN.2012.04.008
Donald C. McMillan, Joseph E. M. Crozier, Khalid Canna, Wilson J. Angerson, Colin S. McArdle, Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. International Journal of Colorectal Disease. ,vol. 22, pp. 881- 886 ,(2007) , 10.1007/S00384-006-0259-6
Donald C. McMillan, The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treatment Reviews. ,vol. 39, pp. 534- 540 ,(2013) , 10.1016/J.CTRV.2012.08.003
Ellen Heitzer, Peter Ulz, Jochen B Geigl, Circulating Tumor DNA as a Liquid Biopsy for Cancer Clinical Chemistry. ,vol. 61, pp. 112- 123 ,(2015) , 10.1373/CLINCHEM.2014.222679
Rafael Sirera, Roy M. Bremnes, Andrea Cabrera, Eloísa Jantus-Lewintre, Elena Sanmartín, Ana Blasco, Nieves del Pozo, Rafael Rosell, Ricardo Guijarro, José Galbis, José Javier Sánchez, Carlos Camps, Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 6, pp. 286- 290 ,(2011) , 10.1097/JTO.0B013E31820189A5
Cecile Bosc, Gilbert R. Ferretti, Jacques Cadranel, Clarisse Audigier-Valette, Benjamin Besse, Fabrice Barlesi, Chantal Decroisette, Sylvie Lantuejoul, François Arbib, Denis Moro-Sibilot, Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC Targeted Oncology. ,vol. 10, pp. 247- 253 ,(2015) , 10.1007/S11523-014-0332-Y